Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

BackgroundCuproptosis, a newly discovered form of cell death, is regulated by protein lipoylation and is related to mitochondrial metabolism. However, further research is needed to determine how the cuproptosis-related gene ferredoxin 1 (FDX1) affects the tumor immune response and its prognostic sig...

Full description

Bibliographic Details
Main Authors: Tao Wang, Yufeng Liu, Qing Li, Yang Luo, Dawei Liu, Bin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.999823/full
_version_ 1811258481723834368
author Tao Wang
Yufeng Liu
Qing Li
Yang Luo
Dawei Liu
Bin Li
author_facet Tao Wang
Yufeng Liu
Qing Li
Yang Luo
Dawei Liu
Bin Li
author_sort Tao Wang
collection DOAJ
description BackgroundCuproptosis, a newly discovered form of cell death, is regulated by protein lipoylation and is related to mitochondrial metabolism. However, further research is needed to determine how the cuproptosis-related gene ferredoxin 1 (FDX1) affects the tumor immune response and its prognostic significance in clear cell renal cell carcinoma (ccRCC).MethodsThe Cancer Genome Atlas was used to screen for FDX1 gene expression in ccRCC and healthy tissue samples. The results were validated using the Gene Expression Omnibus and the Human Protein Atlas. Multivariable analysis and Kaplan-Meier survival curves were used to examine the relationship between FDX1 gene expression, clinicopathological parameters, and overall survival (OS). The protein network containing FDX1 gene interaction was constructed using the online Search Tool for the Retrieval of Interacting Genes/Proteins. The relationship between FDX1 gene expression and immune cell infiltration in ccRCC was examined using Gene Ontology, gene set enrichment analysis (GSEA), and a single-sample GSEA. Using the Gene Expression Profiling Interactive Analysis and Tumor Immune Estimation Resource databases, we investigated the relationship between FDX1 gene expression, the degree of immune cell infiltration, and the corresponding gene marker sets.ResultsccRCC samples had significantly (p < 0.05) lower FDX1 gene expression levels than normal tissue samples. Lower FDX1 gene expression levels were strongly associated with higher cancer grades and more advanced tumor–node–metastasis stages. The findings of multivariate and univariate analyses illustrated that the OS in ccRCC patients with low FDX1 expression is shorter than in patients with high FDX1 expression (p < 0.05). Ferredoxin reductase and CYP11A1 are key proteins interacting with the FDX1 gene, and ccRCC with an FDX1 enzyme defect was associated with a low number of invading immune cells and their corresponding marker.ConclusionIn ccRCC, decreased FDX1 expression was linked to disease progression, an unfavorable prognosis, and dysregulated immune cell infiltration.
first_indexed 2024-04-12T18:14:05Z
format Article
id doaj.art-979171c163f140eea2265b58084171e3
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T18:14:05Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-979171c163f140eea2265b58084171e32022-12-22T03:21:41ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.999823999823Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinomaTao WangYufeng LiuQing LiYang LuoDawei LiuBin LiBackgroundCuproptosis, a newly discovered form of cell death, is regulated by protein lipoylation and is related to mitochondrial metabolism. However, further research is needed to determine how the cuproptosis-related gene ferredoxin 1 (FDX1) affects the tumor immune response and its prognostic significance in clear cell renal cell carcinoma (ccRCC).MethodsThe Cancer Genome Atlas was used to screen for FDX1 gene expression in ccRCC and healthy tissue samples. The results were validated using the Gene Expression Omnibus and the Human Protein Atlas. Multivariable analysis and Kaplan-Meier survival curves were used to examine the relationship between FDX1 gene expression, clinicopathological parameters, and overall survival (OS). The protein network containing FDX1 gene interaction was constructed using the online Search Tool for the Retrieval of Interacting Genes/Proteins. The relationship between FDX1 gene expression and immune cell infiltration in ccRCC was examined using Gene Ontology, gene set enrichment analysis (GSEA), and a single-sample GSEA. Using the Gene Expression Profiling Interactive Analysis and Tumor Immune Estimation Resource databases, we investigated the relationship between FDX1 gene expression, the degree of immune cell infiltration, and the corresponding gene marker sets.ResultsccRCC samples had significantly (p < 0.05) lower FDX1 gene expression levels than normal tissue samples. Lower FDX1 gene expression levels were strongly associated with higher cancer grades and more advanced tumor–node–metastasis stages. The findings of multivariate and univariate analyses illustrated that the OS in ccRCC patients with low FDX1 expression is shorter than in patients with high FDX1 expression (p < 0.05). Ferredoxin reductase and CYP11A1 are key proteins interacting with the FDX1 gene, and ccRCC with an FDX1 enzyme defect was associated with a low number of invading immune cells and their corresponding marker.ConclusionIn ccRCC, decreased FDX1 expression was linked to disease progression, an unfavorable prognosis, and dysregulated immune cell infiltration.https://www.frontiersin.org/articles/10.3389/fimmu.2022.999823/fullferredoxin 1FDX1clear cell renal cell carcinomaimmune cellsprognosis
spellingShingle Tao Wang
Yufeng Liu
Qing Li
Yang Luo
Dawei Liu
Bin Li
Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
Frontiers in Immunology
ferredoxin 1
FDX1
clear cell renal cell carcinoma
immune cells
prognosis
title Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
title_full Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
title_fullStr Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
title_full_unstemmed Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
title_short Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
title_sort cuproptosis related gene fdx1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
topic ferredoxin 1
FDX1
clear cell renal cell carcinoma
immune cells
prognosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.999823/full
work_keys_str_mv AT taowang cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT yufengliu cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT qingli cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT yangluo cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT daweiliu cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT binli cuproptosisrelatedgenefdx1expressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma